Shire says ADHD drug to be reviewed as eating-disorder treatment

SHARE Shire says ADHD drug to be reviewed as eating-disorder treatment

A Shire Plc drug will get a priority review for treating adults with binge eating disorder.

The Irish drugmaker said Monday that Vyvanse will be considered as a treatment for binge eating disorder by the U.S. Food and Drug Administration. The drug is already approved in the U.S. for treating attention-deficit/hyperactivity disorder.

Shire, which is being acquired by North Chicago-based AbbVie, said it expects a decision from the FDA by February.

The Latest
State Sen. Darren Bailey had been seeking Trump’s endorsement for months. The downstate farmer met with Trump last year and attended a fundraiser in April in which he snapped a photo with the former president.
Offense has scored three runs in its last three losses to the Orioles, who entered Saturday’s game with a 4.10 ERA - 12th in the AL
“The risk to residents of suburban Cook County remains low, but we want individuals to be aware of the signs and symptoms of monkeypox so that they seek medical care if they develop,” said Dr. LaMar Hasbrouck, CCDPH chief operating officer.
Hoerner has set career highs in RBI and home runs already this season.
The players are Andrew Vaughn, Jose Abreu, Tim Anderson, AJ Pollock and Luis Robert